Myocarditis & Pericarditis after mRNA COVID-19 Vaccination: New Clinical Resources

The Canadian Cardiovascular Society National Active Surveillance Study of MYocarditis and/or Pericarditis following mRNA COVID-19 VACCination (MYCOVACC) is a unique Canada-wide project funded by the Public Health Agency of Canada. This three-year study involves more than 30 adult and pediatric sites from all parts of the country. Alongside the study, the MYCOVACC team has developed resources to support patient care. Join Dr. Michael McDonald, member of the MYCOVACC Steering Committee, as he discusses new clinical resources about post-vaccine myocarditis and pericarditis available on the CCS website: www.ccs.ca/mycovacc/. Production of this podcast has been made possible through a financial contribution from the Public Health Agency of Canada. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.